Susan M. Domchek
Breast Cancer Research Foundation(US)University of Cambridge(GB)American Association For Cancer Research(US)Medizinische Hochschule Hannover(DE)California University of Pennsylvania(US)Penn Center for AIDS Research(US)University of Pennsylvania Health System(US)University of Pennsylvania(US)
Publications by Year
Research Areas
BRCA gene mutations in cancer, PARP inhibition in cancer therapy, Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Nutrition, Genetics, and Disease
Most-Cited Works
- → Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation(2017)3,123 cited
- → Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation(2014)1,667 cited
- → Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial(2010)1,629 cited
- → Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,581 cited
- → Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality(2010)1,454 cited
- → Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma(2003)